Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.39%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
14.06 Down 0.64(4.35%) 4:00PM EDT
|After Hours : 14.06 0.00 (0.00%) 5:27PM EDT
Prev Close:14.70
Open:14.57
Bid:10.80 x 14500
Ask:18.00 x 300
1y Target Est:27.00
Beta:2.01
Next Earnings Date: 7-Aug-14VNDA Earnings announcement
Day's Range:13.87 - 15.10
52wk Range:5.70 - 19.25
Volume:1,003,394
Avg Vol (3m):812,623
Market Cap:476.25M
P/E (ttm):N/A
EPS (ttm):-1.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VNDADown 4.35%476.25M
AZNDown 0.27%91.54B
LLYDown 0.62%65.03B
JNJDown 0.19%282.63B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.35
Quarterly EPS Est (Jun-14) :-0.73
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.40

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Vanda Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development and commercialization of pharmaceutical products. Its product portfolio includes HETLIOZ, a product for the treatment of Non-24-Hour Sleep-Wake Disorder; Fanapt... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback